0.34
+4.69%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About SoftMedx Healthcare
Its shares trade on HKEX under the ticker 648.HK. It has been listed since 29 October 1990. In the fiscal year to 31 December 2025, it reported revenue of HK$68.2m and net income of HK$7.0m. At that date it held total assets of HK$48.6m and shareholders' equity of HK$27.4m.
China Wah Yan Healthcare Ltd. is an investment holding company, which engages in medical and healthcare businesses. The company employs 120 full-time employees The firm operates through three segments. Health Management segment is engaged in health management-related businesses. Medical and Well-being segment is engaged in tumor diagnosis and treatment, eye caring businesses, pharmaceutical manufacture, medical laboratory testing and gynecology and obstetrics businesses in China. Asset Management segment is engaged in the investment in financial assets, fixed assets and distressed assets, as well as loan financing.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 29 Oct 1990
- Employees
- 120
- Website
- chinawahyan.com ↗
Leadership
Pay as last reported
- Mr. Pinzhuo LinExecutive Director, since 2023
- Sung Him LamCompany Secretary
- Mr. Ho Wai NgokNon-Executive Independent Director
- Ms. Cuihuen TangNon-Executive Independent Director
- Mr. Chun Wing YiuNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- China Wah Yan Healthcare Ltd has a strong market presence in the healthcare industry, with a wide range of products and services offered to its customers.
- The company has established a strong brand reputation, known for its high-quality and reliable healthcare products.
- China Wah Yan Healthcare Ltd has a well-established distribution network, allowing it to reach a large customer base across China.
Weaknesses
- One of the weaknesses of China Wah Yan Healthcare Ltd is its heavy reliance on the domestic market, which makes it vulnerable to changes in government policies and regulations.
- The company may also face challenges in expanding its operations globally due to potential cultural and market differences.
- China Wah Yan Healthcare Ltd may lack diversification in its product offerings, which could limit its growth opportunities in the long term.
Opportunities
- The healthcare industry in China is growing rapidly due to an aging population and increased healthcare awareness, presenting significant growth opportunities for China Wah Yan Healthcare Ltd.
- The company could explore strategic partnerships or acquisitions to expand its product portfolio and reach new customer segments.
- China Wah Yan Healthcare Ltd can leverage advancements in technology to develop innovative healthcare solutions and enhance its competitive advantage.
Threats
- Intense competition in the healthcare industry may pose a threat to China Wah Yan Healthcare Ltd's market share and profitability.
- Economic fluctuations and regulatory changes could impact the company's financial performance and operations.
- The company may face reputational risks if there are issues related to product quality or safety.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.